Academia Sinica yesterday approved the resignation of distinguished research fellow Chen Ching-shih (陳慶士) after news of research misconduct in eight of his published papers was made public by the Ohio State University, where he previously served as a cancer researcher.
Academia Sinica said in a statement that it is sorry to hear about the incident, but added that Chen’s misconduct occurred before he became head of Academia Sinica’s Institute of Biological Chemistry in August 2014.
The institution’s Research Ethics Committee would still look into work he performed while serving at the academy, the statement added.
Chen’s resignation from the Academia Sinica comes after academic journal Science and the university issued separate reports on Friday regarding the findings of research misconduct that led to his resignation as a cancer researcher from the university last year.
The reports said the investigation found Chen had “intentionally committed research misconduct” in 14 instances in eight journal articles, and was guilty of “deviating from the accepted practices of image handling and figure generation and intentionally falsifying data.”
Chen admitted to the charges and resigned in September last year, the university said.
The university said it has requested an “immediate retraction” of the papers, published between 2006 and 2014, that contain the fabricated data.
However, the implications of the misconduct go beyond unreliable academic papers, as Chen’s work had raised millions of US dollars in funding and led to multiple patents and the establishment of two compounds in clinical trials.
The university said it immediately shut down a clinical trial of one of Chen’s anti-cancer agents that Arno Therapeutics Inc had been conducting after obtaining exclusive rights to test the agents.
A spokesperson for the company said that issues with Chen’s papers had “zero impact” on its drug development efforts, Science said.
The university said it “hired an external consultant who validated that Chen’s research misconduct did not affect the Arno licensed compounds developed in his lab.”
“Patient safety was never compromised,” the university’s statement said.
The university said it has forwarded the investigation to federal authorities, meaning Chen could continue to be investigated for his actions.
Academia Sinica first became aware of the matter about a year ago, but it had limited access to Chen’s questionable articles because the university did not reveal its investigation on its Web site until Friday, Academia Sinica Central Academic Advisory Committee executive secretary Henry Sun (孫以瀚) said yesterday.
This is the worst punishment a Taiwanese academic has ever received from a foreign institution, dealing a heavy blow to the nation’s image in international academia, Sun said.
Sun quoted Chen as saying that his laboratory staff “beautified” data to make their research look better, and that he was responsible for lax supervision.
Yesterday morning, Chen’s profile was accessible on the Institute of Biological Chemistry’s Web site, but it was later taken down after Chen tendered his verbal resignation to Academia Sinica president James Liao (廖俊智).
Meanwhile, China Medical University, where Chen in February temporarily served as the director of its Institute of New Drug Development, yesterday said it is unclear about the matter and is collecting information about the case.
Before Chen returned to Taiwan to serve as director of the Institute of Biological Chemistry in August 2014 — a position he held until August last year — he had taught at the Ohio State University’s College of Pharmacy, the University of Rhode Island and the University of Kentucky.
Specializing in medicinal chemistry, cancer studies, biological chemistry and translational medicine, Chen has received research awards from the US Prostate Cancer Foundation and the Hearst Foundation, and is a fellow at the American Association for the Advancement of Science.
In April last year, he and National Cheng Kung University researchers found a relation between vitamin E and cancer prevention, and created an anti-tumor agent that is 20 times more efficient than previous ones, which was then considered a potential opportunity to develop a new anti-cancer drug.
‘UNACCEPTABLE’: The foreign ministry said that China’s behavior broke international law, while Johnny Chiang was worried such balloons could be used against Taiwan A suspected Chinese surveillance balloon flying over the US was yesterday condemned by officials in Taipei and sparked calls for the government to plan countermeasures. The Pentagon on Thursday said it had detected a Chinese surveillance balloon flying over the country. Beijing has said the balloon is a civilian meteorological device that drifted into US territory after being blown off course. The National Security Bureau and Ministry of National Defense should investigate whether surveillance balloons could be used against Taiwan and prepare to respond to such acts, Chinese Nationalist Party (KMT) Legislator Johnny Chiang (江啟臣) said. US Secretary of State Antony Blinken’s postponement
INTELLIGENCE VALUE: While the US was working on recovering the balloon’s remains, China said that it reserved ‘the right to make ... necessary responses’ US President Joe Biden’s administration lauded the Pentagon for shooting down an alleged Chinese spy balloon off the US Atlantic coast on Saturday, but China angrily voiced its “strong dissatisfaction” at the move, and said it might make “necessary responses.” The craft spent several days flying over North America before it was targeted off the coast of the southeastern state of South Carolina with a missile fired from an F-22 plane, Pentagon officials said. It fell into relatively shallow water just 14m deep. US Secretary of Defense Lloyd Austin called the operation a “deliberate and lawful action” that came in response to China’s
RISK FACTOR: ASEAN issued a statement saying the cross-strait situation ‘could lead to miscalculation,’ but it is willing to facilitate dialogue to ensure stability in the region The Ministry of Foreign Affairs yesterday welcomed a joint statement by ASEAN leaders voicing concerns that the situation across the Taiwan Strait could affect regional stability. The statement was issued after the ASEAN Foreign Ministers’ Retreat ended on Saturday in Jakarta. It was the first major meeting since Indonesia assumed chairmanship of ASEAN this year. Attendees of the meeting reiterated their determination to promote “sustainable peace, security, stability, and prosperity within and beyond the region,” the statement said. They expressed concerns about developments across the Taiwan Strait and their “implications on regional stability,” the statement said. The cross-strait situation “could lead to miscalculation, serious
THINK TANK VISIT: The former US Indo-Pacific official said that a capture of Taiwan’s outlying islands by China rather than a large-scale attack is a grave security concern The US and Taiwan can deepen their relations on many fronts, former head of the US Indo-Pacific Command Philip Davidson said yesterday while visiting President Tsai Ing-wen (蔡英文) at the Presidential Office. Davidson is leading a six-member delegation from the National Bureau of Asian Research, a US-based think tank. They arrived on Monday and are scheduled to depart tomorrow. Tsai met with the delegation yesterday morning, welcoming the organization on its first visit to Taiwan since the start of the COVID-19 pandemic, the office said in a statement. She thanked Davidson, a retired admiral, for paying close attention to matters regarding the Taiwan
RSS